Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/15/2025

Colorectal Cancer Screening Recommendations

Age-Based Screening

  • The USPSTF recommends that clinicians selectively offer colorectal cancer screening in adults aged 76 to 85 years, as the net benefit is small in this age group 1, 2
  • Screening decisions for adults 76-85 years should be individualized based on overall health status and ability to undergo treatment if cancer is detected 1
  • Prior screening history is crucial, with those who have never been screened more likely to benefit from screening 1, 2
  • Life expectancy is also a key factor, with screening most appropriate for those with a life expectancy of 10+ years 3
  • The American College of Physicians recommends against screening for adults 86 years and older 4, 5

Screening Options

  • Colonoscopy allows for direct visualization of the entire colon and immediate removal of precancerous polyps, with benefits including detection of colorectal cancer and removal of precancerous lesions 5, 6
  • The American Gastroenterological Association recommends colonoscopy every 10 years if normal 3
  • Cologuard, a non-invasive stool test, has superior sensitivity compared to FIT for detecting colorectal cancer (92.3% vs 73.8%) and is better at detecting advanced precancerous lesions than FIT 7
  • The American College of Gastroenterology recommends Cologuard every 3 years 7

Risk-Benefit Assessment

  • The risk of serious complications from colonoscopy increases with age, and prior screening history is crucial in determining the benefit of additional screening 5
  • The American Society of Clinical Oncology recommends considering prior screening history and overall health status when deciding on screening 1, 2
  • The time to benefit from screening may exceed life expectancy in many adults over 75, and screening is generally not recommended for adults with limited life expectancy 3

Recommendation Algorithm

  • Assessing prior screening history is crucial, with those who have never been screened potentially benefiting more from screening 1, 2
  • Evaluating overall health status and life expectancy is also important, with screening considered for those with a life expectancy of 10+ years and good functional status 3
  • Choosing a screening method based on patient preference and risk profile is recommended, with colonoscopy providing the most comprehensive evaluation for those willing to undergo invasive testing 3
  • The National Comprehensive Cancer Network recommends discussing the risks and benefits of screening with patients and considering their preferences when making a decision 7